{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:36:24Z","timestamp":1793939784265,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>To assess shifts in long-term survival outcomes for prostate cancer patients, the present study conducted conditional survival (CS) analysis and developed a personalized CS-nomogram to provide dynamic prognostic predictions. Data from 301,441 prostate cancer patients in the Surveillance, epidemiology, and end results (SEER) database were analyzed, with cancer-specific survival (CSS) estimated using the Aalen Johansen estimator. Key predictive factors, including tumor size, lymph node involvement, distant metastasis, and histological grade, were identified via LASSO and multivariable Cox regression analyses to construct the nomogram. Results showed an increase in 12-year CSS from 94.3% at diagnosis to 99.4% for those surviving more than 5 years, with prostate cancer-specific mortality falling below 5% after 5\u20136 years of survival. The CS-nomogram demonstrated high predictive accuracy, achieving a concordance index (C-index) of 0.869 and area under the curve (AUC) values between 0.847 and 0.904 over a 12-year follow-up period, which provides dynamic, individualized prognostic estimates, supporting the long-term management of prostate cancer patients.<\/jats:p>","DOI":"10.1038\/s41598-025-00420-9","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:08:45Z","timestamp":1748441325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Conditional survival analysis and real-time prognosis prediction for prostate cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"1","key":"420_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L. et al. Cancer statistics, 2025. CA Cancer J. Clin. 75 (1), 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"issue":"10437","key":"420_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James, N. D. et al. The lancet commission on prostate cancer: Planning for the surge in cases. Lancet 403 (10437), 1683\u20131722 (2024).","journal-title":"Lancet"},{"issue":"17","key":"420_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jama.2024.4011","volume":"331","author":"RM Martin","year":"2024","unstructured":"Martin, R. M. et al. Prostate-specific antigen screening and 15-Year prostate cancer mortality: A secondary analysis of the CAP randomized clinical trial. JAMA 331 (17), 1460\u20131470 (2024).","journal-title":"JAMA"},{"key":"420_CR4","doi-asserted-by":"publisher","first-page":"e077738","DOI":"10.1136\/bmj-2023-077738","volume":"386","author":"S Vaccarella","year":"2024","unstructured":"Vaccarella, S. et al. Prostate cancer incidence and mortality in Europe and implications for screening activities: Population based study. BMJ 386, e077738 (2024).","journal-title":"BMJ"},{"key":"420_CR5","doi-asserted-by":"crossref","unstructured":"Zitricky, F., F\u00f6rsti, A., Hemminki, A., Hemminki, O. & Hemminki, K. Conditional survival in prostate cancer in the nordic countries elucidates the timing of improvements. Cancers 15 (16) (2023).","DOI":"10.3390\/cancers15164132"},{"issue":"9","key":"420_CR6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ijc.34416","volume":"152","author":"K Hemminki","year":"2023","unstructured":"Hemminki, K. et al. Long-term survival trends in solid cancers in the nordic countries marking timing of improvements. Int. J. Cancer 152 (9), 1837\u20131846 (2023).","journal-title":"Int. J. Cancer"},{"issue":"9","key":"420_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"Parker, C. et al. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31 (9), 1119\u20131134 (2020).","journal-title":"Ann. Oncol."},{"issue":"15","key":"420_CR8","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1200\/JCO.2009.25.9697","volume":"28","author":"ML Janssen-Heijnen","year":"2010","unstructured":"Janssen-Heijnen, M. L. et al. Clinical relevance of conditional survival of cancer patients in Europe: Age\u2010specific analyses of 13 cancers. J. Clin. Oncol. 28 (15), 2520\u20132528 (2010).","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"420_CR9","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1158\/1078-0432.Ccr-14-2154","volume":"21","author":"S Hieke","year":"2015","unstructured":"Hieke, S., Kleber, M., K\u00f6nig, C., Engelhardt, M. & Schumacher, M. Conditional survival: A useful concept to provide information on how prognosis evolves over time. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 21 (7), 1530\u20131536. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-2154 (2015).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"20","key":"420_CR10","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1002\/cncr.28273","volume":"119","author":"EC Zabor","year":"2013","unstructured":"Zabor, E. C., Gonen, M., Chapman, P. B. & Panageas, K. S. Dynamic prognostication using conditional survival estimates. Cancer 119 (20), 3589\u20133592. https:\/\/doi.org\/10.1002\/cncr.28273 (2013).","journal-title":"Cancer"},{"issue":"7","key":"420_CR11","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1245\/s10434-020-08235-w","volume":"2","author":"AEJ Latenstein","year":"2020","unstructured":"Latenstein, A. E. J. et al. Conditional survival after resection for pancreatic cancer: A population-based study and prediction model. Ann. Surg. Oncol. 2 (7), 2516\u20132524. https:\/\/doi.org\/10.1245\/s10434-020-08235-w (2020).","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"420_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamaoncol.2018.2442","volume":"4","author":"DS Swords","year":"2018","unstructured":"Swords, D. S., Mulvihill, S. J., Firpo, M. A. & Scaife, C. L. Causes of death and conditional survival estimates of medium- and long-term survivors of pancreatic adenocarcinoma. JAMA Oncol. 4 (8), 1129\u20131130. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2442 (2018).","journal-title":"JAMA Oncol."},{"issue":"5","key":"420_CR13","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1245\/s10434-012-2723-6","volume":"20","author":"JL Dikken","year":"2013","unstructured":"Dikken, J. L. et al. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann. Surg. Oncol. 20 (5), 1623\u20131630. https:\/\/doi.org\/10.1245\/s10434-012-2723-6 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"420_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26049","author":"MM Shah","year":"2020","unstructured":"Shah, M. M. et al. Conditional survival analysis of hepatocellular carcinoma. J. Surg. Oncol. https:\/\/doi.org\/10.1002\/jso.26049 (2020).","journal-title":"J. Surg. Oncol."},{"key":"420_CR15","doi-asserted-by":"publisher","first-page":"106013","DOI":"10.1016\/j.ijsu.2021.106013","volume":"92","author":"L Han","year":"2021","unstructured":"Han, L. et al. Nomogram of conditional survival probability of long-term survival for metastatic colorectal cancer: A real-world data retrospective cohort study from seer database. Int. J. Surg. 92, 106013. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106013 (2021).","journal-title":"Int. J. Surg."},{"issue":"8","key":"420_CR16","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S1470-2045(21)00274-6","volume":"22","author":"A Gafita","year":"2021","unstructured":"Gafita, A. et al. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: An international, multicentre, retrospective study. Lancet Oncol. 22 (8), 1115\u20131125 (2021).","journal-title":"Lancet Oncol."},{"key":"420_CR17","doi-asserted-by":"publisher","first-page":"104313","DOI":"10.1016\/j.ijmedinf.2020.104313","volume":"145","author":"RO Alabi","year":"2021","unstructured":"Alabi, R. O. et al. Comparison of nomogram with machine learning techniques for prediction of overall survival in patients with tongue cancer. Int. J. Med. Inf. 145, 104313 (2021).","journal-title":"Int. J. Med. Inf."},{"issue":"3","key":"420_CR18","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1002\/cam4.5137","volume":"12","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer. Cancer Med. 12 (3), 2600\u20132613 (2023).","journal-title":"Cancer Med."},{"key":"420_CR19","unstructured":"National Cancer Institute. Surveillance, epidemiology, and end results (SEER) program research data (accessed 10 April 2024); http:\/\/www.seer.cancer.gov"},{"issue":"3","key":"420_CR20","doi-asserted-by":"publisher","first-page":"e222246","DOI":"10.1001\/jamanetworkopen.2022.2246","volume":"5","author":"MM Desai","year":"2022","unstructured":"Desai, M. M. et al. Trends in incidence of metastatic prostate cancer in the US. JAMA Netw. Open. 5 (3), e222246\u2013e222246 (2022).","journal-title":"JAMA Netw. Open."},{"key":"420_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejca.2022.08.015","volume":"175","author":"J Hemminki","year":"2022","unstructured":"Hemminki, J., F\u00f6rsti, A., Hemminki, A. & Hemminki, K. Survival trends in solid cancers in the nordic countries through 50 years. Eur. J. Cancer 175, 77\u201385 (2022).","journal-title":"Eur. J. Cancer"},{"key":"420_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1634\/theoncologist.2010-0338","volume":"16","author":"M Riihimaki","year":"2011","unstructured":"Riihimaki, M., Thomsen, H., Brandt, A., Sundquist, J. & Hemminki, K. What do prostate cancer patients die of? Oncologist 16, 175\u2013181 (2011).","journal-title":"Oncologist"},{"issue":"15","key":"420_CR23","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1200\/jco.2009.25.9697","volume":"28","author":"ML Janssen-Heijnen","year":"2010","unstructured":"Janssen-Heijnen, M. L. et al. Clinical relevance of conditional survival of cancer patients in Europe: Age-specific analyses of 13 cancers. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 28 (15), 2520\u20132528. https:\/\/doi.org\/10.1200\/jco.2009.25.9697 (2010).","journal-title":"J. Clin. Oncol. Off J. Am. Soc. Clin. Oncol."},{"issue":"36","key":"420_CR24","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1200\/jco.2014.55.1713","volume":"32","author":"ML Kurta","year":"2014","unstructured":"Kurta, M. L. et al. Prognosis and conditional disease-free survival among patients with ovarian cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 32 (36), 4102\u20134112. https:\/\/doi.org\/10.1200\/jco.2014.55.1713 (2014).","journal-title":"J. Clin. Oncol. Off J. Am. Soc. Clin. Oncol."},{"issue":"8","key":"420_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1634\/theoncologist.2009-0211","volume":"15","author":"RM Merrill","year":"2010","unstructured":"Merrill, R. M. & Hunter, B. D. Conditional survival among cancer patients in the united States. Oncologist 15 (8), 873\u2013882. https:\/\/doi.org\/10.1634\/theoncologist.2009-0211 (2010).","journal-title":"Oncologist"},{"issue":"12","key":"420_CR26","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","volume":"6","author":"RT Dess","year":"2020","unstructured":"Dess, R. T. et al. Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging collaboration for cancer of the prostate. JAMA Oncol. 6 (12), 1912\u20131920 (2020).","journal-title":"JAMA Oncol."},{"issue":"2","key":"420_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2-1","volume":"79","author":"TM Pisansky","year":"1997","unstructured":"Pisansky, T. M. et al. A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma. Cancer 79 (2), 337\u2013344 (1997).","journal-title":"Cancer"},{"key":"420_CR28","unstructured":"Gillessen, S. et al. Management of patients with advanced prostate cancer-metastatic and\/or castration\u2010resistant prostate cancer: Report of the advanced prostate cancer consensus conference (APCCC) 2022. Eur. J. Cancer 185, 178\u2013215 (2023)."},{"issue":"17","key":"420_CR29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy, F. C. et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N. Engl. J. Med. 388 (17), 1547\u20131558 (2023).","journal-title":"N. Engl. J. Med."},{"key":"420_CR30","doi-asserted-by":"publisher","first-page":"102256","DOI":"10.1016\/j.artmed.2022.102256","volume":"125","author":"S Chi","year":"2022","unstructured":"Chi, S. et al. A novel lifelong machine learning-based method to eliminate calibration drift in clinical prediction models. Artif. Intell. Med. 125, 102256 (2022).","journal-title":"Artif. Intell. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00420-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00420-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00420-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:08:47Z","timestamp":1748441327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00420-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00420-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18711"}}